key: cord-0868864-bgto4xfe authors: Mardani, Masoud; Mardani, Sayna; Asadi Kani, Zahra; Hakamifard, Atousa title: An extremely rare mucocutaneous adverse reaction following COVID‐19 vaccination: Toxic epidermal necrolysis date: 2022-03-09 journal: Dermatol Ther DOI: 10.1111/dth.15416 sha: 08b91ff446915567426f9f99fcbba96809d49fe7 doc_id: 868864 cord_uid: bgto4xfe Stevens‐Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), is a type of delayed hypersensitivity reaction that requires urgent medical intervention. In the COVID‐19 era, COVID‐19 vaccines are currently being widely administered and mucocutaneous adverse reactions following vaccination have been reported; however, severe cutaneous adverse reactions associated with COVID‐19 vaccines including SJS/TEN, are extremely rare. Herein, we describe a case of COVID‐19 vaccination induced TEN which developed 1 day after receiving the first dose of Sinopharm COVID‐19 vaccine with favorable clinical outcome. Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), a distinct form of erythema multiforme, is a rare and potentially lifethreatening delayed hypersensitivity reaction that affect the skin and mucous membranes. This entity is often drug related, although infections such as Mycoplasma pneumonia can also be the cause. The incidence is estimated to be 0.4-1.9 cases per million population per year worldwide and the mortality rate is approximately 25%-30%. [1] [2] [3] SJS/TEN are characterized by mucocutaneous tenderness and hemorrhagic erosions with erythema and epidermal detachment presenting as blisters and areas of denuded skin. 3 Vaccination-induced SJS/TEN is much more rare and reported with a number of vaccination. 4 Herein; we described a very rare case of COVID-19 vaccination induced TEN that developed 1 day after receiving the first dose of Sinopharm COVID-19 vaccine. Immunological reactions to vaccines, can be divided to serum sickness, immediate hypersensitivity, and also delayed hypersensitivity reactions. Delayed-type hypersensitivity reactions are often T-cell mediated and SJS/TEN is one of the examples. In T-cell mediated reactions, the release of granzyme and perforin can lead to cell apoptosis. 17 Cytotoxic CD8+ T lymphocytes can be detected in the blister fluid and also perivascular superficial dermis. There is a strong evidence that the Fas ligand (FasL), a form of tumor necrosis factor secreted by lymphocytes, bind to the Fas receptor, which is expressed by keratinocyte. In addition, granulysin, a cytotoxic molecule, resulting in cytotoxicity. Hence; CD8+ T-cells in addition to these cytotoxic molecules are the key factors for the keratinocyte apoptosis in SJS/TEN. 3 Clinical manifestations of this type of hypersensitivity reaction, generally occurs within 6 h to weeks ranging from localized to disseminated mucocutaneous lesions. 18 It is believed that these events are the result of the response to virotopes antigen of vaccine in most of the cases. These virotopes antigen are preferentially expressed on the surface of keratinocytes, hence; lead to CD8+ T lymphocyte activation against epidermal cells and epidermal cells apoptosis with detachment at the dermal-epidermal junction occur. 19, 20 4 | CONCLUSION Our case highlights a very rare COVID-19 vaccine associated mucocutaneous adverse reaction and physicians should be aware of this F I G U R E 3 Histopathologic examination revealed skin tissues with erosive and necrotic sub-epidermal blister containing dense fibrinous exudate which covered by totally necrotic epidermal roof. Sparse infiltrate of lymphocytic inflammatory cells around superficial blood vessels are shown in upper dermis. Direct immunofluorescence test on the skin biopsy was negative reaction type following vaccination. However, because of an extremely rare adverse reaction, there should be no doubt about the COVID-19 vaccination. The authors declare that they have no competing interest. Masoud Mardani, Sayna Mardani, and Atousa Hakamifard: acquired and interpreted the data. Histopathologic result was provided by Zahra Asadi Kani. Atousa Hakamifard wrote the first draft of the manuscript. All authors have read and approved the final manuscript. Written informed consent was obtained from the patient for the use of image and publication of case details in the manuscript. Data sharing is not applicable to this case report type article as no new data were created or analyzed in this study. https://orcid.org/0000-0001-9456-2239 Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system. The pediatric infectious disease journal Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis Toxic epidermal necrolysis (Lyell's disease) The quadrivalent human papillomavirus vaccine: erythema multiforme and cutaneous side effects after administration SARS-CoV-2 vaccines in advanced clinical trials: where do we stand Cutaneous adverse reactions associated with SARS-CoV-2 vaccines Cutaneous and allergic reactions due to COVID-19 vaccinations: a review What to Do If You Have an Allergic Reaction after Getting a COVID-19 Vaccine. Centers for Disease Control and Prevention Adverse reactions to vaccines practice parameter 2012 update Toxic epidermal necrolysis post COVID-19 vaccination-first reported case Stevens-Johnson syndrome due to COVID-19 vaccination Covid-19 vaccine induced Steven-Johnson syndrome: a case report Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Cellular and molecular immunology Controversies in drug allergy: testing for delayed reactions Immunemediated adverse reactions to vaccines An extremely rare mucocutaneous adverse reaction following COVID-19 vaccination: Toxic epidermal necrolysis